Monocyte Chemoattractant Protein–1 Blockade Inhibits Lung Cancer Tumor Growth by Altering Macrophage Phenotype and Activating CD8+Cells-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Monocyte Chemoattractant Protein–1 Blockade Inhibits Lung Cancer Tumor Growth by Altering Macrophage Phenotype and Activating CD8+Cells

Published:2011-02 Issue:2 Volume:44 Page:230-237
ISSN:1044-1549
Container-title:American Journal of Respiratory Cell and Molecular Biology
language:en
Short-container-title:Am J Respir Cell Mol Biol

Author:

Fridlender Zvi G.,Kapoor Veena,Buchlis George,Cheng Guanjun,Sun Jing,Wang Liang-Chuan S.,Singhal Sunil,Snyder Linda A.,Albelda Steven M.

Publisher

American Thoracic Society

Subject

Cell Biology,Clinical Biochemistry,Pulmonary and Respiratory Medicine,Molecular Biology

Reference49 articles.

1. Improving Antitumor Immune Responses by Circumventing Immunoregulatory Cells and Mechanisms

2. Immunosuppressive Strategies that are Mediated by Tumor Cells

3. CCL2 (monocyte chemoattractant protein-1) and cancer

4. CCL2 as an Important Mediator of Prostate Cancer Growth In Vivo through the Regulation of Macrophage Infiltration

5. Preferential migration of regulatory T cells mediated by glioma-secreted chemokines can be blocked with chemotherapy

Cited by 129 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hesperidin PLGA nanoparticles potentiate the efficacy of aPD-1 in treating triple negative breast cancer by regulating CCL2 and ADPN expression in cancer-associated adipocytes;International Immunopharmacology;2024-10

2. AVJ16 inhibits the RNA binding protein IGF2BP1 in lung adenocarcinomas and prevents tumor growth in mice;2024-08-17

3. The Aryl Hydrocarbon Receptor Controls IFNγ-Induced Immune Checkpoints PD-L1 and IDO via the JAK/STAT Pathway in Lung Adenocarcinoma;2024-08-13

4. High-motility pro-tumorigenic monocytes drive macrophage enrichment in the tumor microenvironment;2024-07-18

5. Chemokines in the tumor microenvironment: implications for lung cancer and immunotherapy;Frontiers in Immunology;2024-07-16

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3